Detalles de la búsqueda
1.
Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing.
Int J Clin Oncol;
29(2): 96-102, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38183554
2.
Validation of the initial brain metastasis velocity in non-small cell lung cancer at a single cancer center.
J Neurooncol;
162(2): 435-441, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36977845
3.
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis.
Invest New Drugs;
40(2): 411-419, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716848
4.
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study.
BMC Cancer;
22(1): 1047, 2022 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36203123
5.
Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study.
BMC Cancer;
21(1): 1247, 2021 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798865
6.
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
Cancer;
126(16): 3648-3656, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32484914
7.
Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.
Oncologist;
25(4): e668-e674, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31771990
8.
Phase II study of nab-paclitaxel + carboplatin for patients with non-small-cell lung cancer and interstitial lung disease.
Cancer Sci;
110(12): 3738-3745, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31608537
9.
Osimertinib for patients with EGFR T790M mutation-positive non-small-cell lung cancer and a poor performance status.
Jpn J Clin Oncol;
49(7): 671-675, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30920616
10.
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter.
Cancer Sci;
109(8): 2539-2548, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29900633
11.
Prognostic Factors and Efficacy of First-Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
Oncologist;
23(10): 1210-1217, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567820
12.
Dasatinib Suppresses TGFß-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
Lung;
196(5): 531-541, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29926178
13.
Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study.
BMC Cancer;
17(1): 302, 2017 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28464801
14.
Frequency of EGFR T790M mutation and multimutational profiles of rebiopsy samples from non-small cell lung cancer developing acquired resistance to EGFR tyrosine kinase inhibitors in Japanese patients.
BMC Cancer;
16(1): 864, 2016 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821131
15.
Treatments and outcomes of advanced/recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.
Jpn J Clin Oncol;
46(12): 1135-1142, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27655904
16.
The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.
Int J Clin Oncol;
20(4): 668-73, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25343946
17.
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
Sci Rep;
14(1): 7641, 2024 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561461
18.
Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer.
Thorac Cancer;
15(6): 477-485, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38243641
19.
Continuous vs. Fixed 2-year Duration Immune Checkpoint Inhibitor Treatment of Patients With Non-Small Cell Lung Cancer: A Single Institution Database Analysis.
Clin Lung Cancer;
24(6): 498-506.e3, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37407292
20.
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non-small-cell lung cancer.
Thorac Cancer;
14(5): 442-449, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36523162